Journal of Dental Pathology and Medicine
Open Access

Osteonecrosis; Avascular necrosis; Bone death; Blood supply; Treatment; Corticosteroids; Bone collapse

Osteonecrosis is a debilitating condition that results from the interruption of blood flow to bone tissue, causing the bone cells to die [1]. Without adequate blood supply, the affected bone becomes weak, fragile, and prone to collapse [2]. While osteonecrosis can occur in any bone, it most commonly affects the hip joint, followed by the knee and shoulder. The condition can develop gradually and may remain asymptomatic in its early stages, making it difficult to diagnose until significant damage occurs [3,4]. Understanding the causes, symptoms, diagnosis, and treatment options for osteonecrosis is essential for both prevention and effective management of the condition.

Causes of osteonecrosis

Osteonecrosis can be caused by a variety of factors, many of which interfere with the normal blood supply to the bone. One of the most direct causes of osteonecrosis is trauma to a bone, particularly fractures or dislocations. A fracture near or involving a joint can damage blood vessels, reducing the flow of oxygen and nutrients to the bone tissue [5]. This lack of blood supply can result in bone death, leading to osteonecrosis. The hip is especially vulnerable to osteonecrosis after a hip fracture, particularly in elderly individuals.

Long-term use of corticosteroids (such as prednisone) is a well-established risk factor for osteonecrosis. These medications are often prescribed to treat inflammatory conditions like rheumatoid arthritis or lupus, but prolonged use can impair blood flow to bones. Corticosteroids may cause changes in blood vessels that restrict blood flow, resulting in bone tissue damage [6].

Excessive alcohol consumption is another major risk factor for osteonecrosis. Chronic heavy drinking can lead to the narrowing of blood vessels, reducing blood supply to bones. Alcohol may also increase the production of fat cells, which can block blood vessels in the bone, further contributing to osteonecrosis [7].

This genetic condition causes abnormal red blood cells, leading to blockages in small blood vessels. These blockages can restrict blood flow to bones, particularly in the hips and shoulders.

A systemic autoimmune disease that can cause inflammation and damage to blood vessels, increasing the risk of osteonecrosis [8].

High blood sugar levels over time can damage blood vessels and reduce blood flow to bones.

People with HIV, especially those on antiretroviral therapy, are at increased risk of developing osteonecrosis.

Other Factors

Other potential risk factors for osteonecrosis include radiation therapy, chemotherapy, certain blood disorders, and genetic predisposition. Individuals with a family history of osteonecrosis or those who have had joint surgeries may also be at higher risk. The symptoms of osteonecrosis vary depending on the severity and location of the bone damage. In the early stages, symptoms may be subtle or non-existent, making it difficult to diagnose [9]. The most common symptom of osteonecrosis is pain in the affected joint, which may initially be mild but can become more severe as the bone collapses. The pain often worsens with activity or weight-bearing and may be felt deep within the joint. As the bone weakens and the joint deteriorates, the range of motion may decrease. This can make it difficult to perform daily activities that require the use of the affected joint, such as walking or lifting objects. In some cases, osteonecrosis can cause swelling and inflammation in the affected joint, contributing to pain and stiffness [10]. If left untreated, osteonecrosis can lead to complete joint collapse, resulting in severe disability and chronic pain.

Diagnosis of osteonecrosis

Diagnosing osteonecrosis often begins with a thorough physical examination and medical history, including a review of any risk factors such as trauma, corticosteroid use, or alcohol consumption. Imaging studies are crucial for confirming the diagnosis and assessing the extent of bone damage. X-rays can reveal signs of bone damage, such as joint space narrowing, bone collapse, or changes in bone structure. However, early-stage osteonecrosis may not show up on X-rays.

MRI is the most sensitive imaging technique for diagnosing osteonecrosis, as it can detect early changes in bone tissue and identify areas of decreased blood flow.

CT scans may be used to provide a more detailed view of bone damage and assess the extent of joint collapse.

In some cases, a bone scan using a radioactive tracer may be performed to detect areas of bone damage.

Treatment options for osteonecrosis

Treatment for osteonecrosis depends on the location and severity of the condition. The primary goals of treatment are to relieve pain, prevent further bone damage, and preserve joint function. Options include:

Nonsteroidal anti-inflammatory drugs (NSAIDs) may be prescribed to manage pain and inflammation. In some cases, corticosteroid injections may provide temporary relief.

Physical therapy may help improve joint mobility and strength, reducing pain and preventing further deterioration.

Resting the affected joint and modifying activities to reduce stress on the joint can help manage symptoms, particularly in the early stages of osteonecrosis.

In cases of early osteonecrosis, core decompression may be performed to relieve pressure on the bone and improve blood flow.

In some cases, bone grafting may be used to promote bone regeneration and healing.

This procedure involves reshaping the bone to relieve stress on the joint and prevent further collapse.

In advanced stages of osteonecrosis, when the bone and joint are severely damaged, total joint replacement (such as hip or knee replacement) may be necessary to restore function and alleviate pain.

Prevention of osteonecrosis

While some risk factors for osteonecrosis, such as trauma and genetic predisposition, cannot be controlled, certain preventive measures can reduce the likelihood of developing the condition. These include:

Limiting the use of corticosteroids and alcohol

Maintaining a healthy lifestyle, including regular exercise and a balanced diet

Managing underlying medical conditions, such as diabetes or lupus, to reduce the risk of osteonecrosis

Conclusion

Osteonecrosis is a serious condition that can lead to significant pain, joint dysfunction, and disability. Early detection and treatment are critical in preventing the progression of the disease and preserving joint function. With proper management, many individuals with osteonecrosis can maintain an active and fulfilling life. Understanding the causes, symptoms, and treatment options for osteonecrosis is essential for both patients and healthcare providers to address the condition effectively.

1. Baïz N (2011)Maternal exposure to air pollution before and during pregnancy related to changes in newborn's cord blood lymphocyte subpopulations. The EDEN study cohort. BMC Pregnancy Childbirth 11: 87.

Indexed at, Google Scholar, Crossref

2. Downs S H (2007)Reduced exposure to PM 10 and attenuated age-related decline in lung function. New Engl J Med 357: 2338-2347.

Indexed at, Google Scholar, Crossref

3. Song C (2017)Air pollution in China: status and spatiotemporal variations. Environ Pollut 227: 334-347

Indexed at, Google Scholar, Crossref

4. Fuchs O (2017)Asthma transition from childhood into adulthood. Lancet Respir Med 5: 224-234.

Indexed at, Google Scholar, Crossref

5. Lin HH (2008)Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factors, modeling study. Lancet 372: 1473-1483.

Indexed at, Google Scholar, Crossref

6. Kristin A (2007)Long-term exposure to air pollution and incidence of cardiovascular events in women. New Engl J Med 356: 905-913.

Indexed at, Google Scholar, Crossref

7. Gauderman WJ (2015)Association of improved air quality with lung development in children. New Engl J Med 372: 905-913.

Indexed at, Google Scholar, Crossref

8. Lelieveld J (2015)The contribution of outdoor air pollution sources to premature mortality on a global scale. Nature 525: 367-371.

Indexed at, Google Scholar, Crossref

9. Di Q. (2017)Air pollution and mortality in the medicare population. New Engl J Med 376: 2513-2522.

Indexed at, Google Scholar, Crossref

10. Christopher (2017)Preterm birth associated with maternal fine particulatematter exposure: a global, regional and national assessment. Environ Int 101: 173-182.

Indexed at, Google Scholar, Crossref